首页> 外文期刊>Therapeutic Drug Monitoring >Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Antipsychotics: Drawbacks of Its Clinical Application
【24h】

Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Antipsychotics: Drawbacks of Its Clinical Application

机译:抗精神病学治疗药物监测的干血斑分析:临床应用的缺点

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Dried blood spot (DBS) sampling offers a minimally invasive sampling method for therapeutic drug monitoring of antipsychotics. To facilitate implementation in clinical practice, the aim of this study was to perform a clinical validation study of a DBS method for quantification of risperidone, aripiprazole, pipamperone, and their major metabolites 9-OH risperidone and dehydro-aripiprazole in a real-life, clinical setting.
机译:背景:干血斑(DBS)抽样提供了一种微创取样方法,用于抗精神病药的治疗药物监测。 为了促进临床实践中的实施,本研究的目的是对DBS方法进行临床验证研究,用于定量Risperidone,AripiPrazole,Pipamemperone及其主要代谢物9-OH Risperidone和脱氢 - 阿里哌唑,在现实生活中, 临床上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号